Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.

Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G, Berneman Z, Jaksic B, Feremans W, Bron D, Sinnige H, Mistrik M, Vreugdenhil G, De Bock R, Nemet D, Gilotay C, Amadori S, de Witte T; EORTC Leukemia Group.

Haematologica. 2010 Sep;95(9):1489-95. doi: 10.3324/haematol.2009.018580. Epub 2010 Apr 7.

2.

Genetically identical twin transplantation for chronic lymphocytic leukemia.

Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, DiPersio J, Feremans W, Foroni L, Goodman S, Prentice G, LeMaistre C, Bandini G, Ferrant A, Jacobsen N, Khouri I, Gale RP, Wiestner A, Giralt S, Montserrat E, Chan WC, Bredeson C; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee.

Leukemia. 2007 Dec;21(12):2452-5. Epub 2007 Aug 30.

PMID:
17728782
3.

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.

Bourhis JH, Bouko Y, Koscielny S, Bakkus M, Greinix H, Derigs G, Salles G, Feremans W, Apperley J, Samson D, Björkstrand B, Niederwieser D, Gahrton G, Pico JL, Goldschmidt H; European Group for Blood and Marrow Transplantation.

Haematologica. 2007 Aug;92(8):1083-90. Epub 2007 Jul 20.

4.

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, Jehn U, Feremans W, Meloni G, Vignetti M, de Witte T, Amadori S.

Haematologica. 2007 Mar;92(3):389-96.

5.

Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.

Vey N, Bosly A, Guerci A, Feremans W, Dombret H, Dreyfus F, Bowen D, Burnett A, Dennis M, Ribrag V, Casadevall N, Legros L, Fenaux P.

J Clin Oncol. 2006 Jun 1;24(16):2465-71. Epub 2006 May 1.

PMID:
16651646
6.

Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.

Knoop C, Kentos A, Remmelink M, Garbar C, Goldman S, Feremans W, Estenne M.

Clin Transplant. 2006 Mar-Apr;20(2):179-87.

PMID:
16640524
7.

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

Choquet S, Leblond V, Herbrecht R, Socié G, Stoppa AM, Vandenberghe P, Fischer A, Morschhauser F, Salles G, Feremans W, Vilmer E, Peraldi MN, Lang P, Lebranchu Y, Oksenhendler E, Garnier JL, Lamy T, Jaccard A, Ferrant A, Offner F, Hermine O, Moreau A, Fafi-Kremer S, Morand P, Chatenoud L, Berriot-Varoqueaux N, Bergougnoux L, Milpied N.

Blood. 2006 Apr 15;107(8):3053-7. Epub 2005 Oct 27.

8.

Long-term remission with surgery for recurrent localized Hodgkin lymphoma.

Kentos A, Rocmans P, Remmelink M, Feremans W.

J Thorac Cardiovasc Surg. 2005 May;129(5):1172. No abstract available.

9.

Essential thrombocythaemia causing massive intra-abdominal thrombosis.

Taccone FS, Feremans W.

Br J Haematol. 2005 Feb;128(3):273. No abstract available.

PMID:
15667527
10.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.

Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G, Peetermans M, Stryckmans P, Willemze R, Feremans W, Jaksic B, Bourhis JH, Burghouts JP, de Witte T; EORTC Leukemia Group.

Haematologica. 2004 Jul;89(7):809-17.

11.

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujärvi R, Leon Lara A, Marmont A, Martinez AM, Pascual Cascon H, Bocelli-Tyndall C, Gluckman E, Gratwohl A, Tyndall A; EBMT/EULAR Registry.

Ann Rheum Dis. 2004 Aug;63(8):974-81.

12.

Probable rofecoxib-induced thrombocytopenia.

Kentos A, Robin V, Lambermont M, Jurdan M, Pignarelli M, Feremans W.

Rheumatology (Oxford). 2003 May;42(5):699-700. No abstract available.

PMID:
12709555
13.

Atypical recurrent varicella in 4 patients with hemopathies.

Nikkels AF, Simonart T, Kentos A, Liesnard C, Sadzot-Delvaux C, Feremans W, Piérard GE.

J Am Acad Dermatol. 2003 Mar;48(3):442-7.

14.

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.

Ribrag V, Suzan F, Ravoet C, Feremans W, Guerci A, Dreyfus F, Damaj G, Vantelon JM, Bourhis JH, Fenaux P.

Leukemia. 2003 Feb;17(2):319-22.

PMID:
12592329
15.

[Renaissance of thalidomide].

Waelput F, Feremans W, Heenen M, Sternon J.

Rev Med Brux. 2002 Dec;23(6):504-11. Review. French.

PMID:
12584947
16.

[The hematology clinic].

Feremans W, Kentos A, Robin V.

Rev Med Brux. 2002;23 Suppl 2:77-8. French.

PMID:
12584917
17.

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier.

Kentos A, Vekemans M, Van Vooren JP, Lambermont M, Liesnard C, Feremans W, Farber CM.

Bone Marrow Transplant. 2002 Feb;29(3):273-5.

18.

Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.

Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, Binet JL, Feremans W, Marcus R, Bosch F, Verhoef G, Klein M.

J Clin Oncol. 2001 Nov 15;19(22):4252-8.

PMID:
11709569
19.

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.

Blocklet D, Schoutens A, Kentos A, Feremans W.

Eur J Nucl Med. 2001 Sep;28(9):1430-2. No abstract available.

PMID:
11585304
20.

Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma.

Blocklet D, Schoutens E, Kentos A, Feremans W.

Eur J Nucl Med. 2001 Sep;28(9):1432. doi: 10.1007/s002590100576. No abstract available.

PMID:
24578058
21.

Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe.

Gancberg D, Dargent JL, Verhest A, Kentos A, Feremans W, Lohrisch C, Kornreich A.

Cancer Genet Cytogenet. 2001 Jul 15;128(2):172-4. No abstract available.

PMID:
11478300
22.

Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.

Van Den Neste E, Delannoy A, Feremans W, Ferrant A, Michaux L.

Leuk Lymphoma. 2001 Feb;40(5-6):541-50. Review.

PMID:
11426527
23.

Five years of experience with hydroxyurea in children and young adults with sickle cell disease.

Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P, Devalck C, Dresse MF, Feremans W, Hunninck K, Toppet M, Philippet P, Van Geet C, Sariban E.

Blood. 2001 Jun 1;97(11):3628-32.

24.

Trisomy 21 as the sole abnormality in a refractory anemia with ring sideroblasts.

Gancberg D, Kentos A, Dargent JL, Roufosse C, Dzota G, Capel P, Feremans W, Verhest A.

Cancer Genet Cytogenet. 1999 Sep;113(2):180-2.

PMID:
10484988
25.

Subcutaneous panniculitis-like T-cell lymphoma: further evidence for a distinct neoplasm originating from large granular lymphocytes of T/NK phenotype.

Dargent JL, Roufosse C, Delville JP, Kentos A, Delplace J, Kornreich A, Cochaux P, Hilbert P, Pradier O, Feremans W.

J Cutan Pathol. 1998 Aug;25(7):394-400.

PMID:
9765026
26.

Dramatic response to intravenous high dose gamma-globulin in refractory vasculitis of the skin associated with Sjögren's syndrome.

Durez P, Tourné L, Feremans W, Mascart-Lemone F, Heenen M, Appelboom T.

J Rheumatol. 1998 May;25(5):1032-3. No abstract available.

PMID:
9598925
27.

[Disseminated intravascular coagulation syndrome as a manifestation of breast adenocarcinoma metastasis].

Ludwig J, Kentos A, Crenier L, Dargent JL, Capel P, Feremans W.

Rev Med Brux. 1997 Dec;18(6):385-8. French.

PMID:
9481159
28.

Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier.

Schneider E, Lambermont M, Van Vooren JP, Bastin G, Feremans W, Kentos A, Lemoine F, Liesnard C, Delforge ML, Crenier L, Capel P, Farber CM.

Bone Marrow Transplant. 1997 Oct;20(7):611-2.

29.

[Anatomo-clinical conference: lymphoma and mediastinal mass].

Trenschel R, Dagnelie J, Feremans W, Verhest A, Sculier JP.

Rev Med Brux. 1997 Jun;18(3):125-8. French. No abstract available.

PMID:
9273601
30.

All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemia.

Kentos A, Le Moine F, Crenier L, Capel P, Meyer S, Muus P, Mandelli F, Feremans W.

Br J Haematol. 1997 Jun;97(3):685. No abstract available.

PMID:
9207423
31.

Morphologic and phenotypic changes of the leukemic cells in a case of marginal zone B-cell lymphoma.

Dargent JL, Delville JP, Kornreich A, Pradier O, Cochaux P, Velu T, Capel P, Feremans W, Neve P.

Ann Hematol. 1997 Mar;74(3):149-53.

PMID:
9111430
32.

Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation.

Ravoet C, Feremans W, Husson B, Majois F, Kentos A, Lambermont M, Wallef G, Capel P, Beauduin M, Delannoy A.

Bone Marrow Transplant. 1996 Nov;18(5):943-7.

PMID:
8932849
33.

Simplification of the blood stem cell transplantation (BSCT) procedure: large volume apheresis and uncontrolled rate cryopreservation at -80 degrees C.

Feremans WW, Bastin G, Moine FL, Ravoet C, Delville JP, Pradier O, Wallef G, Dupont E, Capel P, Lambermont M.

Eur J Haematol. 1996 May;56(5):278-82.

PMID:
8641400
34.

Cardiac tamponade: the first manifestation of a generalized lymphoma in a patient with HIV infection.

Van Vooren JP, Renard M, Dargent JL, Capel P, Feremans WW, Farber CM.

Eur J Haematol. 1995 Oct;55(4):274. No abstract available.

PMID:
7589348
35.

Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.

Delville JP, Pradier O, Pauwels O, Van Onderbergen A, Kiss R, Feremans W, Capel P.

Am J Hematol. 1995 Jul;49(3):183-93.

PMID:
7604811
36.

PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.

Galand P, Del Bino G, Morret M, Capel P, Degraef C, Fokan D, Feremans W.

Leukemia. 1995 Jun;9(6):1075-84.

PMID:
7596173
37.

CA-125 in primary mediastinal B-cell lymphoma with sclerosis.

Ravoet C, Dargent JL, Le Moine F, Feremans W.

J Clin Oncol. 1995 Feb;13(2):530-1. No abstract available.

PMID:
7741868
38.

Transjugular intrahepatic portosystemic stent-shunt in myeloid metaplasia.

Ravoet C, Devière J, Feremans W, Velu T.

Eur J Haematol. 1995 Feb;54(2):124. No abstract available.

PMID:
7698296
39.

Optimal blood stem cell mobilization using 10 micrograms/kg granulocyte colony-stimulating factor (G-CSF) alone for high-dose melphalan intensification in multiple myeloma: an intrapatient controlled study.

Feremans W, Le Moine F, Ravoet C, Lambermont M, Bastin G, Delville JP, Pradier O, Dupont E, Capel P.

Am J Hematol. 1994 Oct;47(2):135-8.

PMID:
7522395
40.

Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia.

Meyer S, Feremans W, Cantiniaux B, Capel P, Huygen K, Dicato M.

Am J Hematol. 1993 Aug;43(4):307-9.

PMID:
8372813
41.

[Anemia in an elderly man].

Daoud N, Namias B, Penninck D, Delforge A, Feremans W, Capel P.

Rev Med Brux. 1993 Apr;14(4):123-5. French. No abstract available.

PMID:
8502861
42.

Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome.

Coffernils M, Soupart A, Pradier O, Feremans W, Nève P, Decaux G.

J Rheumatol. 1992 Sep;19(9):1425-7.

PMID:
1433011
43.

Bone marrow scintigraphy in lung carcinomas using nanosized colloids: when is it useful and how useful is it?

Bourgeois P, Thimpont J, Feremans W, Malarme M.

Nucl Med Commun. 1992 Jun;13(6):421-8.

PMID:
1328972
44.

[Therapeutic approach in intestinal lymphoma].

Feremans WW.

Acta Gastroenterol Belg. 1992 Mar-Apr;55(2):239-44. Review. French.

PMID:
1632140
45.

Large granular lymphocyte proliferative disease: 21 Belgian cases and review of the literature.

Pierre PG, Bosly A, De Bock R, Debusscher L, Ferrant A, Feremans W, Lacor P, Michaux JL, Van Camp B, Van Hoof A, et al.

Acta Clin Belg. 1992;47(1):21-9. Review.

PMID:
1317080
46.

Anticardiolipin antibodies (ACA) are most often not associated with lupus-like anticoagulant (LLAC) in human immunodeficiency virus (HIV) infection.

Capel P, Janssens A, Clumeck N, Gerard M, Feremans W, Vandevelde D, Fondu P.

Am J Hematol. 1991 Aug;37(4):234-8.

PMID:
1907097
47.

CD71 phenotype and the value of gallium imaging in lymphomas.

Feremans W, Bujan W, Neve P, Delville JP, Schandene L.

Am J Hematol. 1991 Mar;36(3):215-6.

PMID:
1996560
48.

Acute myelofibrosis. Case report and review of the literature.

Morret-Rauis M, Efira A, Capel P, Cantiniaux B, Feremans W.

Eur J Haematol. 1990 Oct;45(4):231-2. No abstract available.

PMID:
2226741
49.

Chronic acquired immunodeficiency syndrome-associated arthritis: a synovial ultrastructural study.

Bentin J, Feremans W, Pasteels JL, Hauzeur JP, Menu R, Appelboom T.

Arthritis Rheum. 1990 Feb;33(2):268-73.

PMID:
2306294
50.

Bone marrow scintigraphy in breast cancer.

Bourgeois P, Gassavelis C, Malarme M, Feremans W, Frühling J.

Nucl Med Commun. 1989 Jun;10(6):389-400.

PMID:
2788844

Supplemental Content

Loading ...
Support Center